Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2020-10-28 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
2020 THIRD QUARTERLY REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled '2020 THIRD QUARTERLY REPORT' and contains detailed financial data for the third quarter of 2020, including revenue, net profit, earnings per share, and other financial indicators. It references compliance with accounting standards and includes management's certification of the financial statements. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full quarterly financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2020
2020-10-28 English
CLOSURE OF REGISTER OF MEMBERS FOR THE THIRD EXTRAORDINARY GENERAL MEETING OF 2020 AND THE SECOND H SHARES CLASS MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the closure of the register of members for an upcoming Extraordinary General Meeting (EGM) and a class meeting. It specifies dates for shareholder eligibility to attend and vote, and mentions that detailed resolutions and notices will be sent later. The document does not contain financial statements, detailed financial data, or the actual meeting materials. It is a notice related to shareholder meeting logistics rather than the meeting materials themselves or voting results. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about meeting arrangements and does not fall into more specific categories like AGM Information or Declaration of Voting Results.
2020-10-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-10-20 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2020-10-16 English
NOTICE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a notice of a board meeting scheduled to consider and approve the third quarterly results for the period ended September 30, 2020. It is an announcement about the timing and agenda of a board meeting rather than the actual quarterly report or financial results. The document is short (1524 characters) and serves as a notification rather than containing substantive financial data or analysis. Therefore, it is not an Interim/Quarterly Report (IR) but rather a Regulatory Filing (RNS) as a general announcement about corporate activities that does not fit other specific categories.
2020-10-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2020
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/09/2020, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions for the issuer Pharmaron Beijing Co., Ltd. The content focuses on share capital changes and confirmations related to securities issued during the month. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory filing reporting monthly share capital movements as required by the stock exchange rules, not a full financial report or announcement of voting results. It fits best under the category of Regulatory Filings (RNS) as a compliance document reporting share capital movements and confirmations to the exchange.
2020-10-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.